News
AbbVie raises dividend and buys $10 billion of shares
AbbVie Inc (ABBV.N) said on Thursday its board had approved a $10 billion stock repurchase program, and the drugmaker also increased its quarterly dividend,...
Press Releases
GSK’S Fluarix Tetra (Influenza Vaccine) for ages six months and older RECEIVES European Approval
GSK announced the expanded indication for Fluarix Tetra (Quadrivalent Influenza Vaccine) has been approved in Europe to include adults and now children from six...
Press Releases
GSK submits landmark IMPACT data to European Medicines Agencies for supporting Trelegy Ellipta
GlaxoSmithKline plc and Innoviva, Inc. announced the submission of the landmark IMPACT data to the European Medicines Agency as part of a type II...
News
FDA approves ODD for selumetinib for treating neurofibromatosis type 1 (NF1): Merck
AstraZeneca and Merck, known as MSD outside the U.S. and Canada, announced that the U.S. FDA has granted Orphan Drug Designation (ODD) for selumetinib,...
News
Merck disappoints by failing in phaseIII study of its drug which cures Alzheimer’s
The drug, verubecestat, was being tested in patients who showed only a glimmer of the symptoms that eventually rob them of memories and basic...
News
Oxford BioMedia could gain $100 million in sanofi invasion target
UK gene cell therapy designer Oxford BioMedica’s shares jumped as much as 11.2% to 12.30 pence this morning after announcing a $100 million collaboration...
News
Pharma pioneer Sanofi guards its Dengvaxia
You do not get severe dengue from the vaccine. Just because you were administered with the vaccine means you’ll get infected. That’s s a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read